Julia E. Tubert & @JenniferH_Ku each presented vaccine research posters @ the #ICPE (International Conference on Pharmacoepidemiology) in Halifax, Novia Scotia, Canada. #KPResearch#ICPE23
Their findings:
Vaccine: https://t.co/EYQDCFBg9f
@medrxivpreprint: https://t.co/NKF2T6rdbC
Treatments for MAC, M. abscessus pulmonary infection often not guideline based
Lead researcher: @JenniferH_Ku
Story: @GoHealio
Published: @CIDJournal the official journal of @IDSAInfo: https://t.co/HAHvpShwKc
#KPResearch
https://t.co/qFsTfN0re1
An infectious disease epidemiologist, Dr. Jennifer Ku is in the first year of her post-doctoral program
@KPSCalResearch. Yet she's already accomplished so much! Read about her work and her life in this Q&A.
@JenniferH_Ku#KPResearch
https://t.co/91WPXFpZpT
New #KPResearch shows #omicron causes less severe disease on average. Even so, Sara Y. Tartof, PhD, w/ @KPSCalResearch, cautions via @AP that on a societal level it's a serious situation and we need to maintain the practices that we know protect us. https://t.co/ISsK2jT0HH
Two doses of the Moderna covid-19 vaccine were highly effective against SARS-CoV-2 variants, finds study, although vaccine effectiveness against infection with the delta variant moderately declined with increasing time since vaccination
https://t.co/P7Hh3JWv6E
@BruxvoortKatia
Vaccine hesitancy as transformation of core beliefs about what we owe one another
🔸Without trust, no sense of common good
🔹Public health effective only when community members share in decisions
🔸Individual flourishing bound up in collective well-being
https://t.co/YLoMiJmwdh
@SarahBAndrea@publichealthpdx I knew this was going to happen!!!! Yay!!!!!🙌👏👍👍👍👍 congrats my dear. You are going to be amazing. Yay to the realization of the bicoastal dream!
Is it time from vaccination or Delta that drives waning of 💉effectiveness?
New @TheLancet study ~3.4 million @Pfizer vaccinated individuals @KPSCalResearch, with a subgroup of their #SARSCoV2 sequenced, shows persistent waning of effectiveness vs infections across variants /1
Effectiveness of mRNA-1273 against Delta, Mu, and other emerging variants
VE vs Delta infection 87%, modest decline from 94% at 14-60 days since 2nd dose to 80% at 151-180 days
VE vs hospitalization high for all variant types (97-98%)
https://t.co/WlZxu8td5D not peer-reviewed
Had a great opportuinity to present my NTM work in an oral presentation at #IDWeek2021!
Tolerability outcomes of multi-drug antibiotic treatment for pulmonary MAC in U.S. Medicare data https://t.co/Jn4ix0ZNkX
@KatCarlsonPhD@MmMiguelmM
Next up in @OHSU_ID faculty 2021 publications, NTM lung surgeries, w/ lots of VATS!
A colaborative project w/ the NTM group at @UTHealthTyler & featuring multiple faculty in the @OHSUSOM, @OHSUsurgery, & @publichealthpdx.
Led the amazing @JenniferH_Ku!
https://t.co/idm4jxYUU4